Request Deal Involvement

OrbiMed led the $61.8m Series B financing round in Sparrow Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

or

Principals

ORBIMED PE

bidder

ORBIMED PE

SPARROW PHARMACEUTICALS

target

SPARROW PHARMACEUTICALS

RIVERVEST VENTURE PARTNERS

bidder

RIVERVEST VENTURE PARTNERS

THOMVEST VENTURES

bidder

THOMVEST VENTURES

US VENTURE PARTNERS (USVP)

bidder

US VENTURE PARTNERS (USVP)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - OrbiMed led the $61.8m Series B financing round in Sparrow Pharmaceuticals.